د.إ100.38
Acne wash to target excess oil
Helps clear acne breakouts, blemishes, pimples
Clinically tested to reduce excess surface oil by upto 47 percent, leaving skin less oily throughout the day
“Amazon is an authorized retailer of La Roche-Posay products.
La Roche-Posay Effaclar Medicated acne wash has been developed with dermatologists. Face wash with [2.0%] Salicylic Acid Acne Medication, helps targets excess oil, pimples, blackheads and whiteheads for clear skin. Clinically tested to reduce excess surface oil by up to 47%, leaving skin less oily throughout the day. Salicylic Acid Acne Medication fights acne breakouts. Exclusive micro-exfoliating Lipo Hydroxy Acid helps target oily areas on the skin surface to provide precise cell-by-cell removal of debris and dirt.
Use as a daily acne wash to fight excess oil and acne. Cleanse 2x daily, morning and evening. Wet face, apply quarter size amount onto fingers, and only using fingertips, apply gently on face in a rotating circular motion. Avoid getting into eyes. Rinse thoroughly. Gently pat dry using a soft towel. Active Ingredient: 2% Salicylic Acid. Inactive Ingredients: Water, sodium laureth sulfate, decyl glucoside, glycerin, sodium chloride, coco-betaine, PEG-150 pentaerythrityl tetrastearate, hexylene glycol, sodium hydroxide, PEG-6 caprylic/capric glycerides, zinc gluconate, tetrasodium EDTA, polyquaternium-47, menthol, capryloyl salicylic acid, citric acid.
Menthol is an ingredient that is used in this product for its cooling effect on the skin.
Product packaging may vary.”
Non-Comedogenic
Acne wash to target excess oil
Helps clear acne breakouts, blemishes, pimples
Clinically tested to reduce excess surface oil by upto 47 percent, leaving skin less oily throughout the day
Acne cleanser formulated with Salicylic Acid and Lipo Hydroxy Acid (LHA)
Tested on sensitive skin; Allergy tested; Dermatologist tested; Non-Comedogenic
Department | |
---|---|
Manufacturer | |
Item model number | |
Product Dimensions | |
Brand |
د.إ100.38
Reviews
There are no reviews yet.